Search for a clinical trial
Other search option(s)
2 Result(s)
Recruiting trial
= ; Ongoing trial
=
; Funded by an IRDiRC member =
; Member of a ERN =
National clinical trial(s)

SPAIN
Madrid
MADRID


A Phase 1/2 First-in-human, 2-part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (Part 1: Open-label) and Repeat Doses (Part 2: Randomized, Double-blind, Placebo-controlled) of UX053 in Patients with GSD III - ES
Hospital Universitario 12 de Octubre

UNITED KINGDOM
Greater Manchester
MANCHESTER